title: Comparison of FLT-PET and FDG-PET for visualization of head and neck squamous cell cancers.
abstract: OBJECTIVE
  We compared 3'[F-18]fluoro-3'-deoxythymidine (FLT) positron emission tomography (PET) and 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) for PET visualization of head and neck squamous cell cancers (HNSCCs) and evaluated which might better reflect proliferative activity as indicated by the Ki-67 index.
  
  
  METHODS
  A total of 43 patients with HNSCCs were examined with FLT-PET and FDG-PET. The PET images were evaluated qualitatively for regions of focally increased metabolism and for semiquantitative analysis the maximum standardized uptake value (SUV) was calculated.
  
  
  RESULTS
  For depiction of primary tumours, the sensitivity of both approaches was 100%. The mean (± SD) SUV for FLT (5.65 ± 2.96) was significantly lower than that for FDG (10.9 ± 4.91; p < 0.0001). No significant differences were found for the T category. However, the mean (± SD) FLT SUV was significantly higher in poorly than in well-differentiated tumours (6.49 ± 3.13 vs. 4.2 ± 2.08; p < 0.04). Similarly, FDG SUVs in poorly and moderately differentiated tumours (12.72 ± 4.8 and 11.46 ± 4.64) were significantly higher than in well-differentiated tumours (7.45 ± 3.51; p < 0.004 and p < 0.02). No significant correlation was observed with the Ki-67 index for either.
  
  
  CONCLUSIONS
  FLT-PET showed as high a sensitivity as FDG-PET for the detection of primary HNSCC lesions, although uptake of FLT was significantly lower than that of FDG.
authors.affiliation: Department of Otolaryngology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa 761-0793, Japan. hiro@med.kagawa-u.ac.jp
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Hoshikawa
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Nishiyama
authors.forename: Takehito
authors.initials: T
authors.lastname: Kishino
authors.forename: Yuka
authors.initials: Y
authors.lastname: Yamamoto
authors.forename: Reiji
authors.initials: R
authors.lastname: Haba
authors.forename: Nozomu
authors.initials: N
authors.lastname: Mori
mesh_terms: D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000000981:diagnostic imaging* / Q000473:pathology; D005260:Female; D006258:Head and Neck Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D049268:Positron-Emission Tomography
references.citation: J Nucl Med. 1995 Oct;36(10):1747-57
references.pmid: 7562038
references.citation: J Nucl Med. 2007 May;48(5):726-35
references.pmid: 17475960
references.citation: J Nucl Med. 2004 Feb;45(2):226-31
references.pmid: 14960640
references.citation: Eur J Nucl Med Mol Imaging. 2004 May;31(5):720-4
references.pmid: 14991243
references.citation: J Laryngol Otol. 1999 Jun;113(6):548-54
references.pmid: 10605586
references.citation: Ann Nucl Med. 2001 Dec;15(6):471-86
references.pmid: 11831394
references.citation: J Nucl Med. 1997 Dec;38(12):1907-11
references.pmid: 9430467
references.citation: J Nucl Med. 2002 Sep;43(9):1210-7
references.pmid: 12215561
references.citation: J Nucl Med. 2001 May;42(5):721-5
references.pmid: 11337566
references.citation: Clin Cancer Res. 2007 Jun 15;13(12):3552-8
references.pmid: 17575218
references.citation: Eur J Nucl Med Mol Imaging. 2007 Oct;34(10):1610-6
references.pmid: 17530250
references.citation: Nuklearmedizin. 2008;47(2):80-5; quiz N12
references.pmid: 18392317
references.citation: Clin Cancer Res. 2006 Aug 1;12(15):4590-7
references.pmid: 16899606
references.citation: Radiology. 2004 May;231(2):305-32
references.pmid: 15044750
references.citation: Eur J Nucl Med Mol Imaging. 2009 Mar;36(3):382-8
references.pmid: 18985344
references.citation: Eur J Nucl Med. 1996 Oct;23(10):1409-15
references.pmid: 8781149
references.citation: Head Neck. 2001 Nov;23(11):942-6
references.pmid: 11754497
references.citation: Mol Imaging Biol. 2006 Jan-Feb;8(1):36-42
references.pmid: 16362149
references.citation: J Nucl Med. 2005 Mar;46(3):400-4
references.pmid: 15750150
references.citation: Cancer Res. 2003 Jul 1;63(13):3791-8
references.pmid: 12839975
references.citation: Eur J Nucl Med Mol Imaging. 2006 Apr;33(4):412-9
references.pmid: 16404598
references.citation: Gut. 2003 Nov;52(11):1602-6
references.pmid: 14570730
references.citation: J Nucl Med. 1984 Jul;25(7):759-64
references.pmid: 6610731
references.citation: Mol Imaging Biol. 2003 Jul-Aug;5(4):257-70
references.pmid: 14499141